Skip to main content
SpringerLink
Log in

Hepatocyte Growth Factor Expression in Dextran Sodium Sulfate-Induced Colitis in Rats

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Hepatocyte growth factor (HGF), a potent inducer of cell migration with morphogenic and mitogenic actions was reported to have key roles in the repair of various tissues. In order to evaluate the role of HGF in the repair process of inflammatory bowel disease, we have investigated the HGF expression in a dextran sodium sulfate (DSS) colitis model. We randomly assigned rats to a colitis group or to a placebo group; the former received a 7-day course of 5% DSS (mw 5 kDa) in drinking water. DSS-induced severe colitis in rats manifested with weight loss, diarrhea, and intestinal bleeding. Animals were killed from day 1 through 7 and on days 9 and 14 after the end of DSS administration. After DSS was withdrawn, disease activity subsided gradually and HGF expression was significantly enhanced along with the augmented expression of IL-1β, TNF-α, and cyclooxygenase-2, accompanied by an increased number of proliferating epithelial cells in colon. These findings suggest that proinflammatory cytokines and cyclooxygenase-2 may have an important role in the mucosal repair in inflammatory bowel disease through increased production of HGF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Dignass AU: Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis 7:68–77, 2001

    Google Scholar 

  2. Kinoshita Y, Kishi K, Asahara M, Matsushima Y, Wang H, Miyazawa K, Kitamura N, Chiba T: Production and activation of hepatocyte growth factor during the healing of rat gastric ulcers. Digestion 58:225–231, 1997

    Google Scholar 

  3. Schmassmann A, Stettler C, Poulsom R, Tarasova N, Hirschi C, Flogerzi B, Matsumoto K, Nakamura T, Halter F: Roles of hepatocyte growth factor and its receptor met during gastric ulcer healing in rats. Gastroenterology 113:1858–1872, 1997

    Google Scholar 

  4. Matsumoto K, Nakamura T: Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239:639–644, 1997

    Google Scholar 

  5. Beck PL, Podolsky DK: Growth factors in inflammatory bowel disease. Inflamm Bowel Dis 5:44–60, 1999

    Google Scholar 

  6. Stoker M, Gherardi E, Perryman M, Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327:239–242, 1987

    Google Scholar 

  7. Nusrat A, Parkos CA, Bacarra AE, Godowski PJ, Delp-Archer C, Rosen EM, Madara JL: Hepatocyte growth factor/ scatter factor effects on epithelia. J Clin Invest 93:2056–2065, 1994

    Google Scholar 

  8. Rubin JS, Chan AM, Bottaro DP, Burges WH, Taylor WG, Cech AC, Hirschfield DW, Wong J, Miki T, Finch PW, Aaronson SA: A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci USA 88:415–419, 1991

    Google Scholar 

  9. Dignass AU, Lynch-Devaney K, Podolsky DK: Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun 202:701–709, 1994

    Google Scholar 

  10. Montesano R, Matsumoto K, Nakamura T, Orci L: Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67:901–908, 1991

    Google Scholar 

  11. Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83:493–501, 1995

    Google Scholar 

  12. Shimada T, Hiraishi H, Terano A: Hepatocyte growth factor protects gastric epithelial cells against ceramide-induced apoptosis through induction of cyclooxygenase-2. Life Sci 68:539–546, 2000

    Google Scholar 

  13. Maffe A, Comoglio PM: HGF controls branched morphogenesis in tubular glands. Eur J Morphol 36:74–81, 1998

    Google Scholar 

  14. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA: Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802–804, 1991

    Google Scholar 

  15. Sonenberg E, Meyer D, Weidner KM, Birchmeier C: Scatter factor/ hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 123:223–235, 1993

    Google Scholar 

  16. Mayer L. IBD: immunologic research at The Mount Sinai Hospital: Mt Sinai J Med 67:208–213, 2000

    Google Scholar 

  17. Hirono I, Kuhara K, Hosaka S, Tomizawa S, Goldberg L: Induction of intestinal tumors in rats by dextran sulfate sodium. J Natl Cancer Inst 66:579–583, 1981

    Google Scholar 

  18. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694–702, 1990

    Google Scholar 

  19. Cooper HS, Murthy SNS, Shah RS, Sedergran DJ: Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69:238–249, 1993

    Google Scholar 

  20. Kitajima S, Takuma S, Morimoto M: Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp Anim 48:137–143, 1999

    Google Scholar 

  21. Andres PG, Beck PL, Mizoguchi E, Mizoguchi A, Bhan AK, Dawson T, Kuziel WA, Maeda N, MacDermott RP, Podolsky DK, Reinecker H: Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. J Immunol 164:6303–6312, 2000

    Google Scholar 

  22. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO: Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107:1643–1652, 1994

    Google Scholar 

  23. Takahashi M, Ota S, Hata Y, Mikami Y, Azuma N, Makamura T, Terano A, Omata M: Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach. J Clin Invest 98:2604–2611, 1996

    Google Scholar 

  24. Bamba H, Ota S, Kato A, Matsuzaki F: Nonsteroidal antiinflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production. Biochem Biophys Res Commun 245:567–571, 1998

    Google Scholar 

  25. Kinoshita Y, Nakata H, Hassan S, Asahara M, Kawanami C, Matsushima Y, Naribayashi-Inomoto Y, Yao Ping Y, Min D, Nakamura A, Chiba T: Gene expression of keratinocyte and hepatocyte growth factors during the healing of rat gastric mucosal lesions. Gastroenterology 109:1068–1077, 1995

    Google Scholar 

  26. Xian CJ, Couper R, Howarth GS, Read LC, Kallincos NC: Increased expression of HGF and c-met in rat small intestine during recovery from methotrexate-induced mucositis. Br J Cancer 82:945–952, 2000

    Google Scholar 

  27. Hirata T, Ukawa H, Yamakuni H, Kato S, Takeuchi K: Cyclooxygenase isozymes in mucosal ulcerogenic and functional responses following barrier disruption in rats stomachs. Br J Pharmacol 122:447–454, 1997

    Google Scholar 

  28. Kazumori H, Ishihara S, Hoshino E, Kawashima K, Moriyama N, Suetsugu H, Sato H, Adachi K, Fukuda R, Watanabe M, Takasawa S, Okamoto H, Fukui H, Chiba T, Kinoshita Y: Neutrophil chemoatractant 2β regulates expression of the Reg gene in injured gastric mucosa in rats. Gastroenterology 119:1610–1622, 2000

    Google Scholar 

  29. Shanahan F: Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 120:622–635, 2001

    Google Scholar 

  30. Matsuda K, Watanabe T, Abo Y, Uchida H, Kawamura YJ, Masaki T, Muto T: Severe complications of ulcerative colitis after high-dose prednisolone and azathioprine treatment. J Gastroenterol 34:390–394, 1999

    Google Scholar 

  31. Bach SP, Renehan AG, Potten CS: Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis 21:469–476, 2000

    Google Scholar 

  32. Podolsky DK: Regulation of intestinal epithelial proliferation: few answers, many questions. Am J Physiol 264:G179–G186, 1993

    Google Scholar 

  33. Nishimura S, Takahashi M, Ota S, Hirano M, Hiraishi H: Hepatocyte growth factor accelerates restitution of intestinal epithelial cells. J Gastroenterol 33:172–178, 1998

    Google Scholar 

  34. Matsumoto K, Okazaki H, Nakamura T: Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem Biophys Res Commun 188:235–243, 1992

    Google Scholar 

  35. Miyazawa K, Shimomura T, Kitamura N: Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem 271:3615–3618, 1996

    Google Scholar 

  36. Papadakis KA, Targan SR: Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 51:289–298, 2000

    Google Scholar 

  37. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I: Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-I in immediate prostaglandin E2 biosynthesis. J Biol Chem 275:32775–32782, 2000

    Google Scholar 

  38. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF: Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115:297–306, 1998

    Google Scholar 

  39. Brzozowski T, Konturek PC, Konturek SJ, Pajdo R, Schuppan D, Drozdowicz D, Ptak A, Pawlik M, Nakamura T, Hahn EG: Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor. J Physiol Pharmacol 51:751–773, 2000

    Google Scholar 

  40. Göke M, Kanai M, Podolsky DK: Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor. Am J Physiol 274:G809–G818, 1998

    Google Scholar 

  41. Tamura M, Arakaki N, Tsubuchi H, Takada H, Daikuhara Y: Enhancement of human hepatocyte growth factor production by interleukin-1α and-1β and tumor necrosis factor-α by fibroblasts in culture. J Biol Chem 268:8140–8145, 1993

    Google Scholar 

  42. Chowdhury A, Fukuda R, Fukumoto S: Growth factor mRNA expression in normal colorectal mucosa and in uninvolved mucosa from ulcerative colitis patients. J Gastroenterol 31:353–360, 1996

    Google Scholar 

  43. Sturm A, Schulte C, Schatton R, Becker A, Cario E, Goebell H, Dignass AU: Transforming growth factor-beta and hepatocyte growth factor plasma levels in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 12:445–450, 2000

    Google Scholar 

  44. Ota S, Tanaka Y, Bamba H, Kato A, Matsuzaki F: Nonsteroidal anti-inflammatory drugs may prevent colon cancer through suppression of hepatocyte growth factor expression. Eur J Pharmacol 367:131–138, 1999

    Google Scholar 

  45. Itoh H, Kataoka H, Tomita M, Hamasuna R, Nawa Y, Kitamura N, Koono M: Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa. Am J Physiol Gastrointest Liver Physiol 278:G635–G643, 2000

    Google Scholar 

  46. Kitamura S, Kondo S, Shinomura Y, Isozaki K, Kanayama S, Higashimoto Y, Minami T, Kiyohara T, Yasunaga Y, Ishikawa H, Ohtani T, Ishiguro S, Matsuzawa Y: Expression of hepatocyte growth factor and c-met in ulcerative colitis. Inflamm Res 49:320–324, 2000

    Google Scholar 

  47. Tarlton JF, Whiting CV, Tunmore D, Bregenholt S, Reimann J, Claesson MH, Bland PW: The role of up-regulated serine proteases and matrix metalloproteinases in the pathogenesis of a murine model of colitis. Am J Pathol 157:1927–1935, 2000

    Google Scholar 

  48. Naka D, Shimomura T, Yoshiyama Y, Sato M, Sato M, Ishii T, Hara H: Internalization and degradation of hepatocyte growth factor in hepatocytes with down-regulation of the receptor/cmet. FEBS Lett 329:147–152, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine II, Shimane Medical University, Izumo, Japan

    Cesar F. Ortega-Cava, Shunji Ishihara, Kousaku Kawashima, Mohammad A.K. Rumi, Hideaki Kazumori, Kyoichi Adachi & Yoshikazu Kinoshita

Authors
  1. Cesar F. Ortega-Cava
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shunji Ishihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kousaku Kawashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohammad A.K. Rumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hideaki Kazumori
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kyoichi Adachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yoshikazu Kinoshita
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ortega-Cava, C.F., Ishihara, S., Kawashima, K. et al. Hepatocyte Growth Factor Expression in Dextran Sodium Sulfate-Induced Colitis in Rats. Dig Dis Sci 47, 2275–2285 (2002). https://doi.org/10.1023/A:1020195513193

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020195513193

Search

Navigation